GoodRx Holdings
GDRX
182 hedge funds and large institutions have $600M invested in GoodRx Holdings in 2025 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 55 increasing their positions, 66 reducing their positions, and 23 closing their positions.
188% more call options, than puts
Call options by funds: $4.01M | Put options by funds: $1.4M
57% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 23
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
12% more capital invested
Capital invested by funds: $537M → $600M (+$63.3M)
7% more funds holding
Funds holding: 170 → 182 (+12)
6.1% more ownership
Funds ownership: 114.11% → 120.21% (+6.1%)
17% less repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 66
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$3.8M |
| 2 |
Renaissance Technologies
New York
|
+$2.55M |
| 3 |
PCM
Pathway Capital Management
Irvine,
California
|
+$2.53M |
| 4 |
Jane Street
New York
|
+$1.75M |
| 5 |
LSV Asset Management
Chicago,
Illinois
|
+$1.66M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
8KM
8 Knots Management
Dallas,
Texas
|
-$8.11M |
| 2 |
ER
EVR Research
Richmond,
Virginia
|
-$5.73M |
| 3 |
LCM
Lakewood Capital Management
New York
|
-$3.16M |
| 4 |
Goldman Sachs
New York
|
-$2.14M |
| 5 |
RRCP
Rip Road Capital Partners
Boston,
Massachusetts
|
-$1.36M |
GDRX Hedge Fund Activity: Q2 2025 in Review
182 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in GoodRx Holdings (GDRX) for Q2 2025, worth a combined $600M — up 12% from $537M a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new GDRX positions and 23 closed out — a net gain of 13 holders — while 55 added to existing stakes and 66 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $3.8M. The largest seller was 8 Knots Management, exiting entirely with an estimated $8.11M sold.
- 182 institutional investors held GoodRx Holdings (GDRX) as of Q2 2025, up from 170 in Q1 2025.
- Funds reported $600M of GoodRx Holdings stock for Q2 2025, up 12% quarter-over-quarter.
- 36 funds opened new GoodRx Holdings positions in Q2 2025 and 23 closed out, a net change of +13 holders.
- The largest GoodRx Holdings buyer in Q2 2025 was Citadel Advisors, an estimated $3.8M added.
- The largest GoodRx Holdings seller in Q2 2025 was 8 Knots Management, an estimated $8.11M sold.
Based on aggregated 13F filings for Q2 2025.